SONOMA PHARMACEUTICALS, INC. Revenue from Contract with Customer, Excluding Assessed Tax
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Revenue from Contract with Customer, Excluding Assessed Tax of $6.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $6.41M, a 59.55% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $5.56M, a 48.14% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $4.35M, a 22.03% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $5.60M, a 56.58% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2026 was $19.53M, a 36.68% increase from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $14.29M, a 12.19% increase from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $12.73M, a 4.05% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $13.27M, a 5.10% increase from fiscal 2022.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.41M 10-Q · filed 2026-08-06 | $11.97M derived: sum of 2 quarters · filed 2026-08-06 | $16.32M derived: sum of 3 quarters · filed 2026-08-06 | $21.92M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $9.91M derived: sum of 2 quarters · filed 2026-06-16 | $15.51M derived: sum of 3 quarters · filed 2026-06-16 | $19.53M 10-K · filed 2026-06-16 | ||
| 2025-12-31 | $4.35M 10-Q · filed 2026-02-10 | $9.95M derived: sum of 2 quarters · filed 2026-02-10 | $13.97M 10-Q · filed 2026-02-10 | $17.72M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-09-30 | $5.60M 10-Q · filed 2025-11-04 | $9.62M 10-Q · filed 2025-11-04 | $13.37M derived: sum of 3 quarters · filed 2026-08-06 | $16.94M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $4.01M 10-Q · filed 2026-08-06 | $7.77M derived: sum of 2 quarters · filed 2026-08-06 | $11.33M derived: sum of 3 quarters · filed 2026-08-06 | $14.91M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $7.32M derived: sum of 2 quarters · filed 2026-06-16 | $10.90M derived: sum of 3 quarters · filed 2026-06-16 | $14.29M 10-K · filed 2026-06-16 | ||
| 2024-12-31 | $3.56M 10-Q · filed 2026-02-10 | $7.14M derived: sum of 2 quarters · filed 2026-02-10 | $10.53M 10-Q · filed 2026-02-10 | $13.97M derived: sum of 4 quarters · filed 2026-02-10 | ||
| 2024-09-30 | $3.58M 10-Q · filed 2025-11-04 | $6.97M 10-Q · filed 2025-11-04 | $10.41M derived: sum of 3 quarters · filed 2025-11-04 | $13.55M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | $3.39M 10-Q · filed 2025-08-07 | $6.83M derived: sum of 2 quarters · filed 2025-08-07 | $9.97M derived: sum of 3 quarters · filed 2025-08-07 | $12.70M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $6.58M derived: sum of 2 quarters · filed 2025-06-17 | $9.31M derived: sum of 3 quarters · filed 2025-06-17 | $12.73M 10-K · filed 2025-06-17 | ||
| 2023-12-31 | $3.14M 10-Q · filed 2025-02-05 | $5.87M derived: sum of 2 quarters · filed 2025-02-05 | $9.30M 10-Q · filed 2025-02-05 | $12.31M derived: sum of 4 quarters · filed 2025-02-05 | ||
| 2023-09-30 | $2.73M 10-Q · filed 2024-11-07 | $6.16M 10-Q · filed 2024-11-07 | $9.17M derived: sum of 3 quarters · filed 2024-11-07 | $12.12M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $3.43M 10-Q · filed 2024-08-08 | $6.44M derived: sum of 2 quarters · filed 2024-08-08 | $9.38M derived: sum of 3 quarters · filed 2024-08-08 | $12.72M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | $5.96M derived: sum of 2 quarters · filed 2024-06-17 | $9.29M derived: sum of 3 quarters · filed 2024-06-17 | $13.27M 10-K · filed 2024-06-17 | ||
| 2022-12-31 | $2.94M 10-Q · filed 2024-02-08 | $6.28M derived: sum of 2 quarters · filed 2024-02-08 | $10.26M 10-Q · filed 2024-02-08 | $12.56M derived: sum of 4 quarters · filed 2024-02-08 | ||
| 2022-09-30 | $3.33M 10-Q · filed 2023-11-13 | $7.31M 10-Q · filed 2023-11-13 | $9.61M derived: sum of 3 quarters · filed 2023-11-13 | $12.51M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $3.98M 10-Q · filed 2023-08-10 | $6.28M derived: sum of 2 quarters · filed 2023-08-10 | $9.18M derived: sum of 3 quarters · filed 2023-08-10 | $12.93M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | $5.20M derived: sum of 2 quarters · filed 2023-06-21 | $8.94M derived: sum of 3 quarters · filed 2023-06-21 | $12.63M 10-K · filed 2023-06-21 | ||
| 2021-12-31 | $2.90M 10-Q · filed 2023-02-14 | $6.65M derived: sum of 2 quarters · filed 2023-02-14 | $10.33M 10-Q · filed 2023-02-14 | $12.49M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-09-30 | $3.74M 10-Q · filed 2022-11-14 | $7.43M 10-Q · filed 2022-11-14 | $9.59M derived: sum of 3 quarters · filed 2022-11-14 | $14.52M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $3.68M 10-Q · filed 2022-08-11 | $5.84M derived: sum of 2 quarters · filed 2022-08-11 | $10.78M derived: sum of 3 quarters · filed 2022-08-11 | $16.55M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | $7.09M derived: sum of 2 quarters · filed 2022-07-13 | $12.86M derived: sum of 3 quarters · filed 2022-07-13 | $18.63M 10-K · filed 2022-07-13 | ||
| 2020-12-31 | $4.94M 10-Q · filed 2022-02-11 | $10.71M derived: sum of 2 quarters · filed 2022-02-11 | $16.47M 10-Q · filed 2022-02-11 | $20.78M derived: sum of 4 quarters · filed 2022-02-11 | ||
| 2020-09-30 | $5.77M 10-Q · filed 2021-11-15 | $11.54M 10-Q · filed 2021-11-15 | $15.85M derived: sum of 3 quarters · filed 2021-11-15 | $20.24M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $5.77M 10-Q · filed 2021-08-16 | $7.25M 10-Q · filed 2020-08-14 | $10.08M derived: sum of 2 quarters · filed 2021-08-16 | $14.47M derived: sum of 3 quarters · filed 2021-08-16 | $19.20M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-14 | $8.71M derived: sum of 2 quarters · filed 2021-07-14 | $13.43M derived: sum of 3 quarters · filed 2021-07-14 | $17.93M 10-K · filed 2021-07-14 | $18.94M 10-K · filed 2020-07-10 | |
| 2019-12-31 | $4.39M 10-Q · filed 2021-02-16 | $9.12M derived: sum of 2 quarters · filed 2021-02-16 | $13.62M 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | $4.73M 10-Q · filed 2020-11-20 | $9.22M 10-Q · filed 2020-11-20 | ||||
| 2019-06-30 | $4.50M 10-Q/A · filed 2020-11-17 | $4.38M 10-Q · filed 2020-08-14 | ||||
| 2019-03-31 | $18.97M 10-K · filed 2020-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |